Risk assessment for cancer induction after low- and high-LET therapeutic irradiation

Strahlentherapie und Onkologie

Volumn 175, Issue SUPPL. 2, 1999, Pages 47-51

  Engels, Hilde ^a,b,e   Menzel, Hans G ^c   Pihet, Pascal ^d   Wambersie, André ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b BELGIAN NUCLEAR RESEARCH CENTRE   (Belgium)

^c EUROPEAN COMMISSION   (Belgium)

^d INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^e UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Cancer induction; LET; Microdosimetry; Radiotherapy; RBE

Indexed keywords

CARBON;

CANCER RADIOTHERAPY; CANCER RISK; CARCINOGENESIS; CHROMOSOME ABERRATION; CONFERENCE PAPER; DOSIMETRY; FAST NEUTRON RADIATION; FISSION NEUTRON; HEAVY ION RADIATION; HUMAN; LINEAR ENERGY TRANSFER;

EID: 0032718398     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03038888     Document Type: Conference Paper

References (20)

1. Alpen EL. Radiation Biophysics. Second Edition, Academic Press, San Diego, USA, 1998.
2. Alpen EL, Powers-Risius P, Curtis SB, et al. Tumorigenic potential of high-Z, high-LET charged particle radiations. Radiation Research 1993;136:382-91.
3. American Association of Physicists in Medicine (AAPM). Total skin electron therapy: technique and dosimetry. Kartzmark CJ (ed.): Report 23. American Institute of Physics, New York, 1987.
4. Boice JD Jr, Engholm G, Kleinerman RA, et al. Radiation dose and second cancer risk in patients treated for cancer of the cervix. Rad Res 1988;116:3-55.
5. Broerse JJ, Van Bekkum DW, Zurcher C. Radiation carcinogenesis in experimental animals. Experientia 1989;vol 45:60-9.
6. Curtis RE, Boice JD Jr, Stovall M, et al. Risk of leukemia after chemotherapy and radiation treatment for breast cancer. New Engl J Med 1992;326:1745-51.
7. Dicello JF, Wasiolek M, Zaider M. Measured microdosimetric spectra of energetic ion beams of Fe, Ar, Ne and C: Limitations of LET distributions and quality factor in radiation effects and space research. IEEE Trans Nucl Sci 1991;38:1203-9.
8. Engels H, Wambersie A. Relative biological effectiveness of neutrons for cancer induction and other late effects: a review of radiobiological data, pp. 54-87, in Engenhart-Cabillic R, Wambersie A (eds): Fast neutrons and hig-LET particles in Cancer Research, Vol 150, Springer-Verlag, Berlin-Heidelberg, 1998.
9. Hall EJ. Neutrons and carcinogenesis: a cautionary tale. In: Breteau N, Le Bourgeois J-P, Barendsen GW, et al. (eds.): Hadrons in radiation therapy. Proceedings of the meeting of the European Heavy Particle Therapy Group, Orléans (France), 4-6 May 1995. Bulletin du Cancer, 1996;83 (suppl 1):43s-6s.
10. Hollander CF, van Zwieten MJ, Broerse JJ. Carcinogenesis studies in Rhesus monkeys after fission neutron and X-irradiation. In: Broerse JJ, Gerber GB (eds): Neutron Carcinogenesis. Commission of the European Communities. Radiation protection. Report EUR 8084 EN, 1982, Luxembourg, p. 183-185.
11. International Commission on Radiological Protection (ICRP). 1990 Recommendations of the International Commission on Radiological Protection. ICRP Publication 60. Pergamon Press, Oxford, 1991.
12. International Commission on Radiological Protection (ICRP). Conversion coefficients for use in radiological protection against external radiation. Report of a Joint Task Group of the International Commission on Radiological Protection (ICRP) and of the International Commisson on Radiation Units and Measurements (ICRU), ICRP Publication 74. Volume 26, Pergamon Press. Oxford, 1996.
13. International Radiation Study Group on Cervical Cancer. Second cancers in relation to radiation treatment for cervical cancer, Day NE and Boice JD Jr. (eds). IARC Sci Publ 1983;52:1-207.
14. Karzmark CJ, Nunan S, Tanabe E. Medical electron accelerators. McGraw-Hill, Inc., Health Professions Division, New York, 1993.
15. Nath R, Epp ER, Laughlin JS, et al. Neutrons from high-energy x-ray medical accelerators: An estimate of risk to the radiotherapy patient, Medical Physics 1984;11:231-41.
16. Sinclair WK. Experimental RBE values of high LET radiations at low doses and the implications for quality factor assignment. Radiation Protection Dosimetry 1985;13(1-4):319-26.
17. Tucker MA, Coleman CN, Cox RS, et al. Risk of second cancers after treatment for Hodgkin's disease. New Engl J Med 1988;318:76-81.
18. United Nations Scientific Committee on the Effects of Atomic Radiations (UNSCEAR), Ionizing radiation: sources and biological effects. 1982 Report to the General Assembly, with annexes. United Nations, New York, 1982.
19. Wambersie A. Neutron therapy: from radiobiological expectation to clinical reality. Radiation Protection Dosimetry 1992;44:379-95.
20. Wambersie A, Gahbauer RA. Medical applications of electron linear accelerators, CERN Accelerator School (CAS), Cyclotrons, linacs and their applications. European organization for Nuclear Research, CERN 96-02, 4 March 1996, pp. 229-48.